Newsnation
@newsnation·2.7M subscribers·86.7K videos
Trump-weight-loss drugs deal will have significant effects: Doctor | Elizabeth Vargas Reports
Posted
November 7, 2025
Views
6,648
Likes
300
Comments
119
Engagement
November 7, 2025
6,648
300
119
6.30%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
4:21Now PlayingDr. Mahsa Tehrani, a board-certified rheumatologist and Will Soliman, former pharmaceutical executive and CEO of the Accreditation Council for Medical Affairs, join NewsNation to discuss the White House’s new plan to save American lives by slashing the price of popular weight-loss drugs Wegovy and Ozempic. President Trump announced the deals alongside pharma executives from Eli Lilly and Novo Nordisk — cutting monthly costs to less than $150 and expanding coverage through Medicare, Medicaid and the upcoming Trump RX program.
Anchor Elizabeth Vargas delivers the biggest stories, without bias or opinion. Watch "Elizabeth Vargas Reports" every weeknight at 7p/6C on NewsNation. #VargasReports
NewsNation is your source for fact-based, unbiased news for all Americans.
More from NewsNation
Get our app
Find us on cable
How to watch on TV or streaming
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
